Enter Note
Done
Go to previous page in this tab
Session
Clinical
Hypertrophic Cardiomyopathy Medical Society Posters
calendar_today
Schedule
edit_square
Notes
editor_choice
Credits
Fri, Nov 07
R04-R05 Posters
6:30pm - 7:30pm (Central)
HCMS.APB
Set Timezone
Timezone
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
PT - Pacific Time
(GMT-07:00) Arizona
MT - Mountain Time
CT - Central Time
ET - Eastern Time
(GMT-05:00) Indiana (East)
—————————–
(GMT-12:00) International Date Line West
(GMT-11:00) Midway Island
(GMT-11:00) Samoa
(GMT-08:00) Tijuana, Baja California
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-06:00) Saskatchewan
(GMT-06:00) Central America
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-05:00) Bogota
(GMT-05:00) Lima
(GMT-05:00) Rio Branco
(GMT-04:30) Caracas
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Manaus
(GMT-04:00) Santiago
(GMT-04:00) La Paz
(GMT-03:30) Newfoundland
(GMT-03:00) Georgetown
(GMT-03:00) Brasilia
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT) Dublin
(GMT) Lisbon
(GMT) London
(GMT) Monrovia
(GMT) Reykjavik
(GMT) Casablanca
(GMT+01:00) Belgrade
(GMT+01:00) Bratislava
(GMT+01:00) Budapest
(GMT+01:00) Ljubljana
(GMT+01:00) Prague
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Warsaw
(GMT+01:00) Zagreb
(GMT+01:00) Brussels
(GMT+01:00) Copenhagen
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) West Central Africa
(GMT+01:00) Amsterdam
(GMT+01:00) Berlin
(GMT+01:00) Rome
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+02:00) Minsk
(GMT+02:00) Cairo
(GMT+02:00) Helsinki
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Istanbul
(GMT+02:00) Jerusalem
(GMT+02:00) Amman
(GMT+02:00) Beirut
(GMT+02:00) Windhoek
(GMT+02:00) Harare
(GMT+02:00) Johannesburg
(GMT+03:00) Kuwait
(GMT+03:00) Riyadh
(GMT+03:00) Baghdad
(GMT+03:00) Nairobi
(GMT+03:00) Tbilisi
(GMT+03:00) Moscow
(GMT+03:00) Volgograd
(GMT+03:30) Tehran
(GMT+04:00) Muscat
(GMT+04:00) Baku
(GMT+04:00) Yerevan
(GMT+05:00) Ekaterinburg
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Calcutta
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Dhaka
(GMT+06:00) Almaty
(GMT+06:00) Novosibirsk
(GMT+06:30) Yangon (Rangoon)
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Bangkok
(GMT+07:00) Jakarta
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Urumqi
(GMT+08:00) Irkutsk
(GMT+08:00) Ulaan Bataar
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Perth
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Darwin
(GMT+09:30) Adelaide
(GMT+10:00) Canberra
(GMT+10:00) Melbourne
(GMT+10:00) Sydney
(GMT+10:00) Brisbane
(GMT+10:00) Hobart
(GMT+10:00) Vladivostok
(GMT+10:00) Guam
(GMT+10:00) Port Moresby
(GMT+11:00) Magadan
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Auckland
(GMT+13:00) Nukualofa
location_on
Route Me
Generic 'disconnected' Message
Description:
The latest topics in hypertrophic cardiomyopathy will be presented in poster format
Communities
Hypertrophic Cardiomyopathy Medical Society
Navigation
Clinical
Program Selection
Sessions
Session Type
Abstract Poster Board Session
Presentations
Presentation
Clinical
Advanced Diagnosis of Hypertrophic Cardiomyopathy with AI-ECG and Differences Based on Race and Subtype
6:30pm-7:30pm Nov 7 (Central)
Myra Lewontin
Presentation
Clinical
Artificial Intelligence-Enabled Electrocardiogram for the Detection of Elevated Filling Pressure in Hypertrophic Cardiomyopathy and Cardiac Amyloidosis
6:30pm-7:30pm Nov 7 (Central)
Robin Van Lerberghe
Presentation
Clinical
Digital Patient Navigator Facilitates And Scales Patient Engagement with the Hypertrophic Cardiomyopathy Association
6:30pm-7:30pm Nov 7 (Central)
Presentation
Clinical
Exercise can alleviate hypertrophic cardiomyopathy induced by the novel MYH7 T265I mutation
6:30pm-7:30pm Nov 7 (Central)
Yanyan Hao
Presentation
Clinical
Five-Year Outcomes of Glucagon-Like Peptide-1 Agonists in Obstructive Hypertrophic Cardiomyopathy: A Population-Based Retrospective Study
6:30pm-7:30pm Nov 7 (Central)
Tze Ern Ong
Presentation
Clinical
Hypertrophic Cardiomyopathy and Exercise: A Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials
6:30pm-7:30pm Nov 7 (Central)
Presentation
Clinical
Impact of Mavacamten and Disopyramide on Left Ventricular Mechanical Dispersion and Ventricular Arrhythmia in Obstructive Hypertrophic Cardiomyopath
6:30pm-7:30pm Nov 7 (Central)
Benay Ozbay
Presentation
Clinical
Impact of Mavacamten on Left and Right Ventricular Function and Hemodynamics in Obstructive Hypertrophic Cardiomyopathy
6:30pm-7:30pm Nov 7 (Central)
Presentation
Clinical
Improving Early Detection of Hypertrophic Cardiomyopathy Using Viz-HCM: A Quality Improvement Initiative Leveraging Artificial Intelligence-Assisted EKG HCM Screening
6:30pm-7:30pm Nov 7 (Central)
Omar M Abdelfattah
Presentation
Clinical
Improving the Content Validity for the Kansas City Cardiomyopathy Questionnaire in Hypertrophic Cardiomyopathy
6:30pm-7:30pm Nov 7 (Central)
Charles Fox Sherrod
Presentation
Clinical
Incidence of Systolic Dysfunction After Alcohol Septal Ablation for Hypertrophic Cardiomyopathy: A Single-Center Experience
6:30pm-7:30pm Nov 7 (Central)
Wais Nasser
Presentation
Clinical
Longterm outcomes of percutaneous endocardial septal radiofrequency ablation for patients with hypertrophic obstructive cardiomyopathy
6:30pm-7:30pm Nov 7 (Central)
Aiju Tian
Presentation
Clinical
Machine Learning–Based Risk Stratification in Hypertrophic Cardiomyopathy: The Added Prognostic Value of Combined Cardiopulmonary Exercise Testing and Stress Echocardiography
6:30pm-7:30pm Nov 7 (Central)
Geza Halasz
Presentation
Clinical
Myosin modulator Aficamten inhibits force in cardiac muscle by altering myosin’s biochemical activity without changing thick filament structure
6:30pm-7:30pm Nov 7 (Central)
Farid Moussavi-Harami
Presentation
Clinical
Natural History and Outcomes of Massive Left Ventricular Hypertrophy in Childhood Hypertrophic Cardiomyopathy
6:30pm-7:30pm Nov 7 (Central)
Robert Przybylski
Presentation
Clinical
One-Year Outcomes of Mavacamten Versus Septal Myectomy in Hypertrophic Cardiomyopathy: A Propensity-Matched Retrospective Cohort Analysis
6:30pm-7:30pm Nov 7 (Central)
Yaman Jarrar
Presentation
Clinical
Outcomes Following Septal Myectomy in Young Patients with Obstructive Hypertrophic Cardiomyopathy
6:30pm-7:30pm Nov 7 (Central)
Daniel Kamna
Presentation
Clinical
Papillary Muscle Anatomy in Hypertrophic Cardiomyopathy: Comparison to Normal and Impact on Outcomes of Septal Myectomy
6:30pm-7:30pm Nov 7 (Central)
Kendra Gilreath
Presentation
Clinical
Perioperative NT-proBNP Change Predicts Adverse Outcomes After Septal Myectomy: A Nonlinear U-Shaped Association in Obstructive Hypertrophic Cardiomyopathy
6:30pm-7:30pm Nov 7 (Central)
Zhengyang Lu
Presentation
Clinical
Prevalence and Risk Markers for Heart Failure in Hypertrophic Cardiomyopathy: A Multicenter Cross-Sectional Study With Central Assessment of Biomarkers and Echocardiograms
6:30pm-7:30pm Nov 7 (Central)
Elizabeth Bigras
Presentation
Clinical
Real-World Sudden Cardiac Death Risk Prediction in Hypertrophic Cardiomyopathy Using State-of-the-Art Thinking Models
6:30pm-7:30pm Nov 7 (Central)
Ronny Schweitzer
Presentation
Clinical
Right Ventricular Role in Heart Failure of Mildly Symptomatic and Asymptomatic Patients with Obstructive Hypertrophic Cardiomyopathy
6:30pm-7:30pm Nov 7 (Central)
Alexander Schulz
Presentation
Clinical
Targeted Therapy Interrupted: Managing Hypertrophic Obstructive Cardiomyopathy in Pregnancy
6:30pm-7:30pm Nov 7 (Central)
Tanzim Bhuiya
Presentation
Clinical
Tethered Patient-Clinician Education to Improve Awareness and Treatment of Hypertrophic Cardiomyopathy (HCM): A Social Media–Driven Approach
6:30pm-7:30pm Nov 7 (Central)
Stephanie Johnson Stephanie Johnson
Generic 'disconnected' Message
